Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Neoplasia (New York, N.Y.)
|
July 24, 2010
How do bisphosphonates inhibit bone metastasis in vivo?
Pierrick G Fournier, Verena Stresing, Frank H Ebetino, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 2, 2009
Agents targeting prostate cancer bone metastasis
Khalid S Mohammad, Pierrick G Fournier, Theresa A Guise, et al.
Bone
|
October 6, 2010
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
Verena Stresing, Pierrick G Fournier, Akeila Bellahcène, et al.
Oncotarget
|
May 7, 2015
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells
Attaya Suvannasankha, Douglas R Tompkins, Daniel F Edwards, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Neoplasia (New York, N.Y.)
|
July 24, 2010
How do bisphosphonates inhibit bone metastasis in vivo?
Pierrick G Fournier, Verena Stresing, Frank H Ebetino, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 2, 2009
Agents targeting prostate cancer bone metastasis
Khalid S Mohammad, Pierrick G Fournier, Theresa A Guise, et al.
Bone
|
October 6, 2010
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
Verena Stresing, Pierrick G Fournier, Akeila Bellahcène, et al.
Oncotarget
|
May 7, 2015
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells
Attaya Suvannasankha, Douglas R Tompkins, Daniel F Edwards, et al.
Page
of 1